Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedDec 23, 2025
DataAggregated Company Financials
Companies15
  • 7D-0.1%
  • 3M19.4%
  • 1Y26.0%
  • YTDn/a

Over the last 7 days, the Pharma industry has remained flat. As for the the longer term, the industry is up 26% over the past 12 months. Looking forward, earnings are forecast to grow by 11% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 24 Dec 2025UK£322.5bUK£89.4bUK£14.6b21.7x22.1x3.6x
Fri, 21 Nov 2025UK£321.0bUK£90.7bUK£14.8b21.6x21.7x3.5x
Sun, 19 Oct 2025UK£297.6bUK£87.7bUK£11.7b20.6x25.4x3.4x
Tue, 16 Sep 2025UK£274.6bUK£87.1bUK£11.6b20.9x23.6x3.2x
Thu, 14 Aug 2025UK£273.9bUK£87.3bUK£11.7b21.3x23.5x3.1x
Sat, 12 Jul 2025UK£263.8bUK£86.2bUK£10.6b27.8x24.9x3.1x
Mon, 09 Jun 2025UK£271.9bUK£86.3bUK£10.6b27.2x25.6x3.1x
Wed, 07 May 2025UK£267.7bUK£87.0bUK£10.7b26.8x25.1x3.1x
Fri, 04 Apr 2025UK£278.8bUK£87.2bUK£9.6b31.9x28.9x3.2x
Sun, 02 Mar 2025UK£289.5bUK£89.0bUK£9.8b29.1x29.7x3.3x
Tue, 28 Jan 2025UK£234.4bUK£75.7bUK£7.8b33.3x30x3.1x
Thu, 26 Dec 2024UK£223.9bUK£75.4bUK£7.8b31.1x28.8x3x
Sat, 23 Nov 2024UK£224.7bUK£75.5bUK£7.8b31.3x28.8x3x
Mon, 21 Oct 2024UK£253.4bUK£72.3bUK£9.0b30.9x28x3.5x
Wed, 18 Sep 2024UK£258.4bUK£71.9bUK£9.0b37.9x28.7x3.6x
Fri, 16 Aug 2024UK£277.3bUK£72.9bUK£9.1b40.7x30.5x3.8x
Sun, 14 Jul 2024UK£259.5bUK£70.7bUK£9.4b32.7x27.5x3.7x
Tue, 11 Jun 2024UK£268.8bUK£71.5bUK£9.6b31.1x28.1x3.8x
Thu, 09 May 2024UK£270.4bUK£72.2bUK£9.6b33.1x28x3.7x
Sat, 06 Apr 2024UK£240.7bUK£70.8bUK£9.7b31.4x24.8x3.4x
Mon, 04 Mar 2024UK£233.3bUK£70.7bUK£9.7b30.9x23.9x3.3x
Wed, 31 Jan 2024UK£237.9bUK£68.9bUK£10.7b36.1x22.3x3.5x
Fri, 29 Dec 2023UK£234.9bUK£68.8bUK£10.7b35.4x22x3.4x
Sun, 26 Nov 2023UK£227.1bUK£69.2bUK£10.7b53x21.2x3.3x
Tue, 24 Oct 2023UK£229.7bUK£70.4bUK£10.3b53.8x22.3x3.3x
Thu, 21 Sep 2023UK£246.6bUK£70.0bUK£10.3b55.1x24x3.5x
Sat, 19 Aug 2023UK£234.0bUK£68.9bUK£10.2b53.5x23x3.4x
Mon, 17 Jul 2023UK£226.8bUK£66.7bUK£7.8b54.3x29.2x3.4x
Wed, 14 Jun 2023UK£250.8bUK£68.1bUK£7.9b54.6x31.7x3.7x
Fri, 12 May 2023UK£257.0bUK£68.4bUK£8.0b58.1x32.3x3.8x
Sun, 09 Apr 2023UK£254.7bUK£69.3bUK£6.9b50.5x37.1x3.7x
Tue, 07 Mar 2023UK£237.3bUK£70.5bUK£7.0b50.3x34.1x3.4x
Thu, 02 Feb 2023UK£230.3bUK£79.3bUK£6.3b38.2x36.5x2.9x
Sat, 31 Dec 2022UK£244.5bUK£80.2bUK£6.3b37.3x38.5x3x
Price to Earnings Ratio

38.5x


Total Market Cap: UK£244.5bTotal Earnings: UK£6.3bTotal Revenue: UK£80.2bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 27.4x202320242025
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 22.1x which is lower than its 3-year average PE of 27.4x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 32% per year over the last three years.
  • Revenues for these companies have grown 3.7% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.K. Pharma compare with similar industries?

GB Market1.27%
Healthcare0.034%
Pharma-0.13%
Pharma-0.13%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AZN AstraZenecaUK£137.361.7%
+UK£3.6b		31.6%PE30.6x
HLN HaleonUK£3.722.4%
+UK£774.9m		-2.7%PE21.8x
HIK Hikma PharmaceuticalsUK£15.261.3%
+UK£42.1m		-23.3%PE12.3x
SAR Sareum HoldingsUK£0.1511.1%
+UK£2.1m		-44.4%PB9.1x
POLB Poolbeg PharmaUK£0.0415.2%
+UK£1.4m		-43.4%PB2.4x

Latest News

GSK
UK£18.15
GSK
7D
-0.3%
1Y
35.5%
HIK
UK£15.26
Hikma Pharmaceuticals
7D
1.3%
1Y
-23.3%
HLN
UK£3.72
Haleon
7D
2.4%
1Y
-2.7%

Is Now The Time To Put Haleon (LON:HLN) On Your Watchlist?

Dec 20
Is Now The Time To Put Haleon (LON:HLN) On Your Watchlist?
STX
UK£0.11
Shield Therapeutics
7D
-2.7%
1Y
296.4%

STX: Future US Label Expansion Could Still Leave Shares Vulnerable

Analysts have raised their price target for Shield Therapeutics from 0.03 dollars to 0.10 dollars, citing slightly stronger long term revenue growth expectations, while applying a higher discount rate and more conservative profit margin and valuation multiples. What's in the News Presentation of pediatric FORTIS PK sub study at the American Society of Hematology conference in December 2025 showed ferric maltol is well absorbed across pediatric age groups, with maltol rapidly metabolized and excreted, supporting its suitability for iron replacement in children and adolescents (company announcement).
AZN
UK£137.36
AstraZeneca
7D
1.7%
1Y
31.6%
HCM
UK£1.93
HUTCHMED (China)
7D
-3.5%
1Y
-20.2%
AGY
UK£0.11
Allergy Therapeutics
7D
-0.4%
1Y
80.0%

Market Participants Recognise Allergy Therapeutics plc's (LON:AGY) Revenues Pushing Shares 30% Higher

Dec 16
Market Participants Recognise Allergy Therapeutics plc's (LON:AGY) Revenues Pushing Shares 30% Higher
INC
UK£0.026
Incanthera
7D
-13.3%
1Y
-50.5%
EAH
UK£1.03
ECO Animal Health Group
7D
-3.3%
1Y
45.1%

Earnings Not Telling The Story For ECO Animal Health Group plc (LON:EAH) After Shares Rise 25%

Dec 04
Earnings Not Telling The Story For ECO Animal Health Group plc (LON:EAH) After Shares Rise 25%
POLB
UK£0.041
Poolbeg Pharma
7D
5.2%
1Y
-43.4%
NFX
UK£0.0022
Nuformix
7D
-10.0%
1Y
350.0%
SAR
UK£0.15
Sareum Holdings
7D
11.1%
1Y
-44.4%
IMM
UK£0.057
ImmuPharma
7D
-7.8%
1Y
359.7%